| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4025216 | Journal Français d'Ophtalmologie | 2009 | 7 Pages |
Abstract
Intravitreal ranibizumab injections appeared to be a good therapeutic option for patients with peripapillary CNV in the short term. Long-term follow-up of these patients will aid in assessing the sustained effect of the drug.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Y. Nochez, M.-L. Le Lez, P.-J. Pisella,